Microbial Production of Galactooligosaccharides

Kitap BölümüYalnız künye
  • SDG 2 · Açlığa Son

Özet

Galactooligosaccharides (GOSs) are prebiotic compounds derived from lactose, known for their ability to selectively promote the growth of beneficial gut microbiota, like bifidobacteria and lactobacilli. Their physiological benefits include enhanced gut health, improved immune function, and increased mineral absorption. Produced primarily through enzymatic synthesis using microbial β-galactosidases, GOSs offer an efficient and environmentally friendly alternative to chemical production methods. Recent advancements in enzyme immobilization and biotechnological approaches have optimized GOS yields, enabling their incorporation into a variety of food and health applications, including infant formulas, dairy products, and clinical supplements. The structural diversity of GOSs, characterized by their glycosidic linkages and degrees of polymerization, contributes to their functional versatility and prebiotic efficacy. Furthermore, their stability under acidic and high-temperature conditions makes them suitable for industrial processes. Despite these advancements, challenges such as cost reduction, process optimization, and the use of alternative substrates persist. Future research on enzyme engineering and tailored GOS formulations is anticipated to address these issues, expanding their applications in functional foods, nutraceuticals, and personalized health solutions. GOSs remain a promising tool for improving health and meeting diverse nutritional needs.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/bayburt/13153Resmi atıflarda kullanılan kalıcı adres
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
0
OpenAlex
0
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDurgut Malçok, Senanur
dc.contributor.authorÖztekin, Sebahat
dc.contributor.authorAdal, Samiye
dc.contributor.authorİnan Çınkır, Nuray
dc.contributor.authorÇelebi, Yasemin
dc.contributor.authorÇalışkan Koç, Gülşah
dc.contributor.authorÖzkan Karabacak, Azime
dc.contributor.authorSüfer, Özge
dc.contributor.authorDelikanlı Kıyak, Berrak
dc.date.accessioned2026-10-29T19:10:33.573846851Z
dc.date.available2026-10-29T19:10:33.573846851Z
dc.date.issued2025
dc.description.abstractGalactooligosaccharides (GOSs) are prebiotic compounds derived from lactose, known for their ability to selectively promote the growth of beneficial gut microbiota, like bifidobacteria and lactobacilli. Their physiological benefits include enhanced gut health, improved immune function, and increased mineral absorption. Produced primarily through enzymatic synthesis using microbial β-galactosidases, GOSs offer an efficient and environmentally friendly alternative to chemical production methods. Recent advancements in enzyme immobilization and biotechnological approaches have optimized GOS yields, enabling their incorporation into a variety of food and health applications, including infant formulas, dairy products, and clinical supplements. The structural diversity of GOSs, characterized by their glycosidic linkages and degrees of polymerization, contributes to their functional versatility and prebiotic efficacy. Furthermore, their stability under acidic and high-temperature conditions makes them suitable for industrial processes. Despite these advancements, challenges such as cost reduction, process optimization, and the use of alternative substrates persist. Future research on enzyme engineering and tailored GOS formulations is anticipated to address these issues, expanding their applications in functional foods, nutraceuticals, and personalized health solutions. GOSs remain a promising tool for improving health and meeting diverse nutritional needs.
dc.identifier.doi10.1007/978-3-031-90974-0_39
dc.identifier.endpage539
dc.identifier.isbn978-303190974-0
dc.identifier.isbn978-303190973-3
dc.identifier.scopus2-s2.0-105023600704
dc.identifier.startpage509
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/bayburt/13153
dc.language.isoen
dc.publisherSpringer Science+Business Media
dc.relation.ispartofMicrobial Production of Food Bioactive Compounds
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectEnzymatic synthesis
dc.subjectFunctional foods
dc.subjectGalactooligosaccharides
dc.subjectGut microbiota
dc.subjectHealth benefits
dc.subjectMicrobial production
dc.subjectPrebiotics
dc.subjectβ-galactosidase
dc.subject.otherBiochemical engineering
dc.subject.otherBiomedical engineering
dc.subject.otherClinical research
dc.subject.otherFood microbiology
dc.subject.otherFunctional food
dc.subject.otherBifidobacterium
dc.subject.otherEnzymatic synthesis
dc.subject.otherFunctionals
dc.subject.otherGalacto-oligosaccharides
dc.subject.otherGut healths
dc.subject.otherGut microbiota
dc.subject.otherHealth benefits
dc.subject.otherMicrobial production
dc.subject.otherPrebiotics
dc.subject.otherβ- Galactosidase
dc.subject.otherCost reduction
dc.titleMicrobial Production of Galactooligosaccharides
dc.typeBook Chapter
rdl.citation.openalex0
rdl.citation.scopus0
rdl.oa.statusclosed
rdl.sdgSDG02
rdl.source.indexSCOPUS